Different clinical value of minimal residual disease after autologous and allogenic stem cell transplantation for chronic lymphocytic leukemia

Blood. 2002 Mar 1;99(5):1873-4. doi: 10.1182/blood.v99.5.1873.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Disease Progression
  • Follow-Up Studies
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell / therapy*
  • Neoplasm, Residual / diagnosis*
  • Transplantation, Autologous
  • Transplantation, Homologous
  • Treatment Outcome